Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    11707753 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Azelastine Fluticasone Combination vs. Fluticasone
Condition: Allergic Rhinitis
Interventions: Drug: Azelastine , fluticasone;   Drug: Fluticasone propionate
2 Completed Differential Adrenoreceptor Mediated Tachyphylaxis and Upregulation
Conditions: Allergic Rhinitis;   Tachyphylaxis;   Rhinitis Medicamentosa
Interventions: Drug: Oxymetazoline 0.05% w/v;   Drug: Fluticasone propionate 50 micrograms per actuation;   Drug: Prazosin hydrochloride;   Drug: Placebo to Prazosin
3 Unknown  Preventing Tolerance to Oxymetazoline in Allergic Rhinitis
Conditions: Allergic Rhinitis;   Tachyphylaxis;   Rhinitis Medicamentosa
Interventions: Drug: oxymetazoline-fluticasone propionate;   Drug: Oxymetazoline
4 Completed To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Drug: levocetirizine;   Drug: placebo to levocetirizine

Indicates status has not been verified in more than two years